Literature DB >> 8466223

The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sézary T cells.

A H Rook, B R Vowels, C Jaworsky, A Singh, S R Lessin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8466223

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  15 in total

1.  Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients.

Authors:  Rachael A Clark; Rei Watanabe; Jessica E Teague; Christoph Schlapbach; Marianne C Tawa; Natalie Adams; Andrew A Dorosario; Keri S Chaney; Corey S Cutler; Nicole R Leboeuf; Joi B Carter; David C Fisher; Thomas S Kupper
Journal:  Sci Transl Med       Date:  2012-01-18       Impact factor: 17.956

2.  Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma.

Authors:  Kei-ichi Yamanaka; Rachael Clark; Benjamin Rich; Rebecca Dowgiert; Kazuki Hirahara; Daniel Hurwitz; Michio Shibata; Nina Mirchandani; David A Jones; Deborah S Goddard; Sara Eapen; Hitoshi Mizutani; Thomas S Kupper
Journal:  Blood       Date:  2005-12-01       Impact factor: 22.113

3.  Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma.

Authors:  Maria Wysocka; Noor Dawany; Bernice Benoit; Andrew V Kossenkov; Andrea B Troxel; Joel M Gelfand; Michael Kelly Sell; Louise C Showe; Alain H Rook
Journal:  Leuk Lymphoma       Date:  2011-10

4.  Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma.

Authors:  M Di Renzo; P Rubegni; G De Aloe; L Paulesu; A L Pasqui; L Andreassi; A Auteri; M Fimiani
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

5.  T cell lymphoid aggregates in idiopathic hypereosinophilic syndrome.

Authors:  D Slater
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

6.  The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.

Authors:  Lisa H Shiue; Jacob Couturier; Dorothy E Lewis; Caimiao Wei; Xiao Ni; Madeleine Duvic
Journal:  Photodermatol Photoimmunol Photomed       Date:  2015-03-28       Impact factor: 3.135

7.  Tumour-specific cytotoxic T lymphocyte activity in Th2-type Sézary syndrome: its enhancement by interferon-gamma (IFN-gamma) and IL-12 and fluctuations in association with disease activity.

Authors:  N Seo; Y Tokura; K Matsumoto; F Furukawa; M Takigawa
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

8.  Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience.

Authors:  B Prinz; W Behrens; E Hölzle; G Plewig
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

9.  Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome.

Authors:  Kelly C G ManfrereC; Marina P Torrealba; Denis R Miyashiro; Nátalli Z Pereira; Fabio S Y Yoshikawa; Luana de M Oliveira; Jade Cury-Martins; Alberto J S Duarte; José A Sanches; Maria N Sato
Journal:  Oncotarget       Date:  2017-09-18

10.  Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients.

Authors:  R J Capocasale; R J Lamb; E C Vonderheid; F E Fox; A H Rook; P C Nowell; J S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.